FYXIAR Trademark

Trademark Overview

On Friday, June 28, 2013, a trademark application was filed for FYXIAR with the United States Patent and Trademark Office. The USPTO has given the FYXIAR trademark a serial number of 85972912. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 8, 2023. This trademark is owned by Glaxo Group Limited. The FYXIAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
fyxiar

General Information

Serial Number85972912
Word MarkFYXIAR
Filing DateFriday, June 28, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 8, 2023
Registration Number5148684
Registration DateTuesday, February 28, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "FYXIAR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Friday, September 8, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 28, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 25, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 17, 2017NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 17, 2017TEAS DELETE 1(B) BASIS RECEIVED
Thursday, July 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 20, 2016SOU EXTENSION 5 GRANTED
Wednesday, June 29, 2016SOU EXTENSION 5 FILED
Wednesday, June 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, December 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 29, 2015SOU EXTENSION 4 GRANTED
Monday, December 21, 2015SOU EXTENSION 4 FILED
Monday, December 21, 2015SOU TEAS EXTENSION RECEIVED
Thursday, June 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2015SOU EXTENSION 3 GRANTED
Tuesday, June 23, 2015SOU EXTENSION 3 FILED
Tuesday, June 23, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 4, 2015SOU EXTENSION 2 GRANTED
Wednesday, December 10, 2014SOU EXTENSION 2 FILED
Friday, January 30, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 10, 2014SOU TEAS EXTENSION RECEIVED
Thursday, June 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 24, 2014SOU EXTENSION 1 GRANTED
Tuesday, June 24, 2014SOU EXTENSION 1 FILED
Tuesday, June 24, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, January 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 29, 2013ASSIGNED TO LIE
Friday, October 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 11, 2013EXAMINER'S AMENDMENT ENTERED
Friday, October 11, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 11, 2013EXAMINERS AMENDMENT E-MAILED
Friday, October 11, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 9, 2013ASSIGNED TO EXAMINER
Thursday, July 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 2, 2013NEW APPLICATION ENTERED

Related Keywords

fyxiar pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological